Merkel cell carcinoma showing regression after biopsy: Evaluation of programmed cell death 1-positive cells

Journal of Dermatology

Volumn 42, Issue 5, 2015, Pages 496-499

  Fujimoto, Noriki ^a   Nakanishi, Gen ^a   Kabuto, Miho ^a   Nakano, Toshiaki ^b   Eto, Hikaru ^b   Nakajima, Hideki ^c   Sano, Shigetoshi ^c   Tanaka, Toshihiro ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

biopsy; Merkel cell carcinoma; polyomavirus; programmed cell death 1; regression

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHROMOGRANIN A; CYTOKERATIN 20; DNA NUCLEOTIDYLEXOTRANSFERASE; PROGRAMMED DEATH 1 RECEPTOR; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR FOXP3;

AGED; APOPTOSIS; ARTICLE; CANCER REGRESSION; CASE REPORT; CELLULAR IMMUNITY; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; JAPANESE (PEOPLE); LYMPHOCYTE; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MICROSCOPY; MONONUCLEAR CELL; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PUNCH BIOPSY; TUMOR BIOPSY; TUMOR IMMUNITY; TUMOR REGRESSION; TUNEL ASSAY; BIOPSY; CHEMISTRY; PATHOLOGY; REMISSION; SKIN TUMOR; VIROLOGY;

AGED; BIOPSY; CARCINOMA, MERKEL CELL; HUMANS; MALE; PROGRAMMED CELL DEATH 1 RECEPTOR; REMISSION, SPONTANEOUS; SKIN NEOPLASMS;

EID: 84928309219     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12805     Document Type: Article

References (11)

1. Dowlatshahi M, Huang V, Gehad AE, et al,. Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol 2013; 133: 1879-1889.
2. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-1100.
3. Nicolaidou E, Mikrova A, Antoniou C, Katsambas AD,. Advances in Merkel cell carcinoma pathogenesis and management: a recently discovered virus, a new international consensus staging system and new diagnostic codes. Br J Dermatol 2012; 166 (1): 16-21.
4. Takenaka H, Kishimoto S, Shibagaki R, Nagata M, Yasuno H,. Merkel cell carcinoma with partial spontaneous regression: an immunohistochemical, ultrastructural, and TUNEL labeling study. Am J Dermatopathol 1997; 19: 614-618.
5. Paulson KG, Iyer JG, Tegeder AR, et al,. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011; 29: 1539-1546.
6. Val-Bernal JF, Garcia-Castano A, Garcia-Barredo R, Landeras R, De Juan A, Garijo MF,. Spontaneous complete regression in merkel cell carcinoma after biopsy. Adv Anat Pathol 2011; 18: 174-177; author reply 177.
7. Sais G, Admella C, Soler T,. Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Venereol 2002; 16 (1): 82-83.
8. Yagi Y, Fujisawa A, Makiura M, Morita K,. Spontaneous regression of Merkel cell carcinoma after biopsy. J Dermatol 2009; 36: 312-313.
9. Triozzi PL, Fernandez AP,. The role of the immune response in merkel cell carcinoma. Cancers (Basel) 2013; 5 (1): 234-254.
10. Koba S, Paulson KG, Nagase K, et al,. Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma. PLoS ONE 2012; 7: e41465.
11. Hamid O, Robert C, Daud A, et al,. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013; 369 (2): 134-144.